Dorsey & Whitney Trust’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-190,560
Closed -$92K 543
2020
Q4
$92K Hold
190,560
0.01% 481
2020
Q3
$104K Hold
190,560
0.01% 421
2020
Q2
$132K Hold
190,560
0.02% 415
2020
Q1
$161K Hold
190,560
0.03% 360
2019
Q4
$313K Buy
190,560
+1,360
+0.7% +$2.04K 0.04% 317
2019
Q3
$210K Buy
189,200
+35,300
+23% +$40.8K 0.03% 382
2019
Q2
$191K Hold
153,900
0.03% 378
2019
Q1
$222K Buy
153,900
+45,380
+42% +$67.3K 0.03% 345
2018
Q4
$128K Hold
108,520
0.02% 356
2018
Q3
$147K Buy
108,520
+14,020
+15% +$22.2K 0.02% 409
2018
Q2
$216K Hold
94,500
0.04% 350
2018
Q1
$143K Hold
94,500
0.03% 361
2017
Q4
$72K Hold
94,500
0.01% 351
2017
Q3
$110K Buy
94,500
+43,100
+84% +$54.3K 0.02% 335
2017
Q2
$89K Buy
51,400
+6,200
+14% +$13.2K 0.02% 331
2017
Q1
$119K Buy
45,200
+6,000
+15% +$21.6K 0.02% 317
2016
Q4
$167K Buy
39,200
+6,100
+18% +$20.1K 0.04% 274
2016
Q3
$88K Buy
+33,100
New +$76.1K 0.02% 285

Other funds holding GEN

Dorsey & Whitney Trust's GEN Position: Q1 2021 in Review

Dorsey & Whitney Trust sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 190,560 shares — an estimated $92K sold.

Dorsey & Whitney Trust first reported a position in GEN in Q3 2016 and held it in 18 quarters. The position peaked at $313K in Q4 2019. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.

  • Dorsey & Whitney Trust reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
  • Dorsey & Whitney Trust sold 190,560 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $92K.
  • Dorsey & Whitney Trust first reported a position in Genesis Healthcare, Inc. in Q3 2016 and held it in 18 quarters.
  • Dorsey & Whitney Trust's Genesis Healthcare, Inc. position peaked at $313K in Q4 2019.
  • 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2021, filed 11 May 2021.